IDH2 and CD28 mutations were seen in only AITL (25%, 4% respectively), and not in PTCL‐TFH, with mutation in the remaining genes being at low frequencies in both groups. The gene discussed is IDH2; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.